News

Gladstone in the News October 7, 2025

CRISPR T-Cells: Programming the Future of Medicine with Alexander Marson

CRISPr T-Cell Therapy: A New Frontier—In this podcast episode, Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, talks about CAR T-cell therapy, using CRISPR to edit T-cells, biotech, and his collaboration with Napster Co-Founder Sean Parker.

Gladstone Experts Genomic Immunology Marson Lab CRISPR/Gene Editing

Gladstone in the News October 6, 2025

Nobel Prize in Physiology or Medicine Is Awarded for Work on Immune Systems

The New York Times—After scientists were awarded the 2025 Nobel Prize in Physiology or Medicine for their discoveries of peripheral immune tolerance, Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, comments on how their work has been central to understanding autoimmune diseases and cancers. (Subscription required.)

Gladstone Experts Autoimmune Diseases Cancer Genomic Immunology Marson Lab

Gladstone in the News September 26, 2025

New Treatment Shows Promise for Huntington’s Disease

The New York Times—Steve Finkbeiner, director of the Center for Systems and Therapeutics at Gladstone, notes that a new gene therapy shows promise for patients affected by Huntington’s disease, but untreated brain regions may still experience neurodegeneration. (Subscription required.)

Gladstone Experts Huntington’s Disease Neurological Disease Center for Systems and Therapeutics Finkbeiner Lab

Gladstone in the News September 22, 2025

Real-Time Molecular Recorders Expose the Inner Lives of Cells

Nature—Gladstone Investigator Seth Shipman weighs in on the promise of DNA-based “molecular recorders” to reveal how cells develop and change in real time.

Gladstone Experts Shipman Lab CRISPR/Gene Editing

Gladstone in the News September 19, 2025

Jennifer Doudna on Vaccinations

The Atlantic (via Instagram)—In this short video clip, Gladstone Investigator Jennifer Doudna explains how vaccinations have been so successful that there's been a collective forgetting that diseases, including measles, used to kill people in fairly large numbers.

Gladstone Experts Doudna Lab

Gladstone in the News September 11, 2025

NIH Funding Cuts Will Cost Lives and Threaten Innovation

San Francisco Business Times—In this commentary, Gladstone President Deepak Srivastava warns that severe funding cuts from the National Institutes of Health would put lifesaving biomedical research—and patients—at risk.

Gladstone Experts Srivastava Lab

Article September 2, 2025

Virologist Viewpoints: The Promise of Cancer Vaccines

Magnus Hoffmann explains the science behind cancer vaccines and how they could change the game.

Gladstone Experts Cancer Infectious Disease

Gladstone in the News August 14, 2025

With Vaccine Research Under Attack, It’s Time for California to Lead Again

The San Francisco Standard—In this opinion piece, Melanie Ott, director of the Gladstone Institute of Virology, writes that halting mRNA research right now is like banning ChatGPT—it's not just scientific negligence, but strategic self-sabotage. She proposes ways for California to take the lead by funding crucial research at the state level.

Gladstone Experts Cancer COVID-19 HIV/AIDS Infectious Disease Ott Lab

Gladstone in the News August 12, 2025

Deepak Srivastava Speaks About the Impact of Proposed NIH Budget Cuts

ABC7 News—Scientific advances have brought us closer than ever to contemplating cures for many devastating diseases—Parkinson’s, type 1 diabetes, certain cancers, HIV/AIDS. Gladstone President Deepak Srivastava comments on how proposed cuts to the National Institutes of Health budget would slow this progress and the very research that could save millions of lives. He explains why this moment matters and why continued investment in science is critical.

Gladstone Experts Srivastava Lab

Gladstone in the News August 8, 2025

Lab-Grown Salmon Introduced by Bay Area-Based Seafood Company

ABC7 News—Gladstone alumnus Arye Elfenbein and his business partner, Justin Kolbeck, founded Wildtype to create cell-cultured seafood. Their company uses the same technology—known as induced pluripotent stem cells—that Elfenbein learned while working in the lab of Deepak Srivastava at Gladstone.

Gladstone Experts Srivastava Lab

Article August 6, 2025

How Do Vaccines Work?

An in-depth explainer about different types of vaccines and what happens in the body after vaccination.

Gladstone Experts COVID-19 Deep Dive

Gladstone in the News August 1, 2025

Jennifer Doudna Is Named 2026 Priestley Medalist

Chemical & Engineering News—Gladstone Investigator Jennifer Doudna is receiving the highest honor given by the American Chemical Society for discoveries on ribozyme function and CRISPR gene editing, and for her international science leadership.

Awards Gladstone Experts Doudna Lab

Video July 30, 2025

Our Research Is Explicitly Focused on Solving Disease | The Gladstone Difference

Gladstone unites more than 600 biologists, chemists, engineers, and data scientists, combining diverse expertise to uncover how the human body functions—and what drives disease.

Communications Gladstone Experts Institutional News

Gladstone in the News July 28, 2025

Gladstone Institutes Develops AI-Powered Thinking Microscope

ABC7 News—Steve Finkbeiner, director of the Center for Systems and Therapeutics at Gladstone, describes the revolutionary thinking microscope that his team developed to help identify better treatments for diseases like Alzheimer’s, Parkinson’s, and ALS.

Gladstone Experts ALS Alzheimer’s Disease Parkinson’s Disease Center for Systems and Therapeutics Finkbeiner Lab

Gladstone in the News July 21, 2025

Two Cancer Drugs Show Surprising Promise in Treating Alzheimer’s

Discover Magazine—With so few Alzheimer’s drugs available, repurposing medications approved for other conditions could be the key to tackling this complex disease. In fact, Gladstone Investigator Yadong Huang and his colleagues at UCSF discovered that a combination of two cancer drugs could reduce brain degeneration and restore memory, pointing toward a potent treatment path never considered before.

Gladstone Experts Alzheimer’s Disease Huang Lab